Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Michaela Pevna
Residual Cancer Lymphocytes in Patients With Chronic Lymphocytic Leukemia After Therapy Show Increased Expression of Surface Antigen CD52 Detected Using Quantitative Fluorescence Cytometry
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Related publications
Ibrutinib Therapy Releases Leukemic Surface IgM From Antigen Drive in Chronic Lymphocytic Leukemia Patients.
Clinical Cancer Research
Cancer Research
Oncology
CD39 Expression on T Lymphocytes Correlates With Severity of Disease in Patients With Chronic Lymphocytic Leukemia
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Anticoagulant Therapy in Patients With Chronic Lymphocytic Leukemia Receiving Ibrutinib
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Minimal Residual Disease Surveillance in Chronic Lymphocytic Leukemia by Fluorescence-Activated Cell Sorting
Rambam Maimonides Medical Journal
Medicine
Transcend CLL 004: Minimal Residual Disease After Lisocabtagene Maraleucel in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Cytotoxic Lymphocytes in B-Cell Chronic Lymphocytic Leukemia
Annals of Hematology
Medicine
Hematology
A Quantitative Analysis of Subclonal and Clonal Gene Mutations Before and After Therapy in Chronic Lymphocytic Leukemia
Clinical Cancer Research
Cancer Research
Oncology
Treatment of Chronic Lymphocytic Leukemia With a Hypomethylating Agent Induces Expression of NXF2, an Immunogenic Cancer Testis Antigen
Clinical Cancer Research
Cancer Research
Oncology
High CD74 Expression Correlates With ZAP70 Expression in B Cell Chronic Lymphocytic Leukemia Patients
Medical Oncology
Medicine
Cancer Research
Oncology
Hematology
